Contrave

Contrave Indications/Uses

Manufacturer:

Patheon

Distributor:

Zuellig

Marketer:

iNova
Full Prescribing Info
Indications/Uses
Contrave is indicated, as an adjunct to a reduced-calorie diet and increased physical activity, for the management of weight in adult patients (≥18 years) with an initial Body Mass Index (BMI) of ≥ 30 kg/m2 (obese), or ≥ 27 kg/m2 to < 30 kg/m2 (overweight) in the presence of one or more weight-related co-morbidities (e.g., type 2 diabetes, dyslipidaemia, or controlled hypertension).
Treatment with Contrave should be discontinued after 16 weeks if patients have not lost at least 5% of their initial body weight (see Pharmacology: Pharmacodynamics under Actions).
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.
Sign up for free
Already a member? Sign in